Upload
iris-caberte
View
220
Download
0
Embed Size (px)
Citation preview
8/4/2019 DRUGS Pleural Effusion 2ndary to CAP
1/6
DRUG INDICATION ACTIONSIDE EFFECTS AND
ADVERSE REACTION
NURSING
CONSIDERATIONPATIENT TEACHING
Generic Name:
Cefuroxime
Brand Name:Zinacef
Classification
Antibiotic
Cephalosporin(second generation)
Dosage
750 mg
Frequency
q8h
Route
IV (-) ANST
Date Started:
June 28, 2011
Helps intreating lower
respiratoy
infectionscaused by H.
influenzae.
Bactericidal:Inhibits
synthesis of
bacterial cellwall of gram-negative
bacteria H.
influenzae
causingweakened cell
wall because ofdefective
structure thus
osmotic lysisoccurs resulting
to cell death.
Side Effects:CNS: headache, dizziness,
paresthesia
GI: stomach upset, moderateto severe diarrhea, nausea,
vomiting, abdominal pain,flatulence
Adverse Effects:GI: hepatotoxicity,pseudomembranous colitis
GU: nephrotoxicity
HEMATOLOGIC: bonemarrow depression (decreasedWBC, decreased platelets,
decreased Hct)
LOCAL: Pain, abcess at
injection site, phlebitis,inflammation at IV site
History: Allergicreaction, hepatic and
renal impairment
Physical: Skin status,liver & renal function
test, CBC, sensitivitytest, signs of
dehydration
Take it on full course asprescribed even if you are
feeling better to avoid
drug resistance.
Avoid alcohol whiletaking this drug and forthree days after because
severe reactions oftenoccur.
Avoid activities thatrequire alertness until
response to medication isknown.
Give without regards tomeals. If GI upset occurs
give with food or milk.
Instruct patient to reportimmediately to healthcareprovider if he/she
experience any side oradverse effects.
8/4/2019 DRUGS Pleural Effusion 2ndary to CAP
2/6
DRUG INDICATION ACTION
SIDE EFFECTS AND
ADVERSE REACTION
NURSING
CONSIDERATIONPATIENT TEACHING
Generic Name:
Azithromycin
Brand Name:
Zithromax
Classification
Macrolide antibiotic
Dosage
500 mg
Frequency
OD for 3 days
Route
Oral
Date Started:
June 28, 2011
Treatment of
mild tomoderate
communityacquiredpneumonia
caused by H.
influenzae.
Bacteriostatic and
bacteriocidalagainst gram-
negative bacteriaH. influenzae:Inhibits protein
synthesis bybinding with the
bacterial ribosomeand mRNA hence
stopping the cell to
produce moreamino acid chains.
In addition to that,it has a higher
concentration ofphagocytes which
the components ofthe drug are
activelytransported to the
site of infectionright away.
Side Effects:CNS
: headache, dizziness,vertigo, fatigue
GI: stomach cramping,diarrhea, nausea, vomiting,
abdominal pain, flatulence,dyspepsia, abnormal taste
Adverse Effects:GI: pseudomembranous
colitis, hepatotoxicity
History:
Hypersensitivity toazithromycin or any
macrolide antibiotics,hepatic or renalimpairment
Physical: skin color,
lesions, orientation,GI output, culture and
sensitivity tests of
infection, urinalysis,renal function test
Take it on full course asprescribed even if you arefeeling better to avoid
drug resistance.
Take oral medication with8 oz water at least 1 hourbefore or 2 hours after
meals.
Do not take azithromycinwith foods or antacids.
Avoid activities thatrequire alertness until
response to medication isknown.
Instruct patient to reportimmediately to healthcareprovider if he/she
experience any side oradverse effects.
8/4/2019 DRUGS Pleural Effusion 2ndary to CAP
3/6
DRUG INDICATION ACTIONSIDE EFFECTS AND
ADVERSE REACTION
NURSING
CONSIDERATIONPATIENT TEACHING
Generic Name:
Ketorolac
Trometamol
Brand Name:
Tral
Classification
Nonopioid analgesicNSAID
Dosage
30 mg
Frequency
Q8h
Route
IV (-) ANST
Date Started:
June 28, 2011
Short-termmanagement of
pain up to 5
days
It inhibitsprostaglandin
synthesis by
blocking COX-1(Cyclooxygenase-1) which results to
the reduction ofpain perceived by
the client(analgesic) and
reduction of signsof inflammation
(anti-
inflammatory).
Side Effects:CNS: headache, dizziness,
drowsiness, fatigue
GI: diarrhea, nausea,vomiting, flatulence,
dyspepsia, constipation
Respiratory: dyspnea,bronchospasm
Adverse Effects:GI: gastric or duodenal
ulcer, dark tarry stool,hematemesis (bright
red/coffee ground emesis),hepatotoxicity
GU: nephrotoxicity
Hematologic: bone
marrow depression(decreased WBC,
decreased platelets,decreased Hct)
LOCAL: Pain, abcess at
injection site, phlebitis,inflammation at IV site
History: Impairedhearing, allergies,
renal impairment;
hepatic, CV, and GIconditions
Physical: skin colorand lesions,
orientation, reflexes,opthalmologic and
audiometricevaluation,
adventitious sounds,
liver evaluation,CBC, renal function
tests, serum test
Avoid activities thatrequire alertness until
response to medication is
known.
Advise patient tominimize GI upset byeating small, frequent
servings of healthy foods.
Instruct patient to avoidaspirin products and herbs
during therapy.
Instruct patient to reportimmediately to healthcareprovider if he/sheexperience any side or
adverse effects.
8/4/2019 DRUGS Pleural Effusion 2ndary to CAP
4/6
DRUG INDICATION ACTIONSIDE EFFECTS AND
ADVERSE REACTION
NURSING
CONSIDERATIONPATIENT TEACHING
Generic Name:
Hyoscine-N-Butyl
Bromide
Brand Name:
Buscopan
Classification
Antispasmodic
Anticholinergic
Dosage
1 amp
Frequency
prn
Route
IV
Date Started:
June 29, 2011
Controlgastric
secretionrelated to
abdominalcramps
Inhibits
acetylcholine
receptor sites at theautonomic nervous
system that controlsthe secretion ofgastric acids.
Patient complained
of intermittent
abdominal pain.
Side Effects:CNS: headache,
dizziness, drowsiness,blurred vision, dilated
pupils
CV: hypertention, chest
pain, tachycardia
GI: nausea, vomiting, dry
mouth, taste loss,constipation
History: Glaucoma,
bronchial asthma,
COPD, myocardialischemia, fever,
diarrhea, heartfailure, hypertension,renal disease, hiatal
hernia
Physical: bowel
sounds, urinaryoutput, adventitious
sounds, IOP, vision,bilateral grip
strength, renalfunction tests, skin
color, lesions
Take 30-60 minutesbefore meals and exactly
as prescribed.
Avoid activities thatrequire alertness untilresponse to medication is
known.
Frequent oral care orsugarless candies willsooth dry mouth.
Instruct patient to reportimmediately to healthcareprovider if he/she
experience any side oradverse effects.
8/4/2019 DRUGS Pleural Effusion 2ndary to CAP
5/6
8/4/2019 DRUGS Pleural Effusion 2ndary to CAP
6/6
DRUG INDICATION ACTIONSIDE EFFECTS AND
ADVERSE REACTION
NURSING
CONSIDERATIONPATIENT TEACHING
Generic Name:
Butamirate Citrate
Brand Name:
Sinecod Forte
Classification:
Antitussive
Dosage
1 tab
Frequency
TID
Route
Oral
Date Started:
June 30, 2011
Relieve hard,dry non-
productivecough of lower
respiratoryinfections
caused by
Haemophilus
influenzae
Acts directly on thebrain cough center,
specifically on thevagus nerve, to
suppress coughreflex. It also tends
to reduce airway
resistance.
Side Effects:CNS: headache,
dizziness, drowsiness,vertigo
Other: skin rashes
Adverse Effects:CV: hypotension
GI: diarrhea, nausea,
vomiting
History: Allergicreaction, hepatic and
renal impairment
Physical: Skin status,renal function test,
CBC, sensitivity test
Avoid activities thatrequire alertness until
response to medication isknown.
Instruct to take severaldeep breaths before
coughing.
Advise to avoid irritantslike fumes, dusk, or
smoke.
Instruct patient to reportimmediately to healthcare
provider if he/sheexperience any side or
adverse effects.